Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 1.00 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.58 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | GLA | P06280 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | THPO | P40225 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | APEX1 | P27695 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.55 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.55 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Histidine SCHEMBL28071764 | 1.00 | CYP3A4 (1.00) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| Histidine SCHEMBL30852263 | 1.00 | CYP3A4 (1.00) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| Histidine SCHEMBL3260 | 1.00 | CYP3A4 (1.00) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| Histidine SCHEMBL137600 | 1.00 | CYP3A4 (1.00) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| D-Histidine SCHEMBL288043 | 1.00 | CYP3A4 (1.00) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| Histidine SCHEMBL19974306 | 1.00 | CYP3A4 (1.00) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| Histidine SCHEMBL25357958 | 0.98 | CYP3A4 (0.97) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| Histidine SCHEMBL25267810 | 0.98 | CYP3A4 (0.97) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| Histidine SCHEMBL6005501 | 0.98 | CYP3A4 (0.97) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 | |
| Histidine SCHEMBL25362582 | 0.98 | CYP3A4 (0.97) | CYP3A4SLC7A5CPB2ALDH1A1HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2252333-A2 | GAS BASED WOUND AND TISSUE THERAPEUTICS | Oxygen Biotherapeutics, Inc. (US) | 2010-11-24 | — | — | EP | claimed |
| WO-2009102487-A2 | GAS BASED WOUND AND TISSUE THERAPEUTICS | OXYGEN BIOTHERAPEUTICS, INC. (US) | 2009-08-20 | — | — | WO | claimed |
| US-20150231177-A1 | Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2015-08-20 | — | — | US | disclosed |
| US-20130289471-A1 | GAS BASED WOUND AND TISSUE THERAPEUTICS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2013-10-31 | — | — | US | disclosed |
| US-20120207793-A1 | Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications | VIRGINIA COMMONWEALTH UNIVERSITY | 2012-08-16 | — | — | US | disclosed |
| US-20120184898-A1 | GAS BASED WOUND AND TISSUE THERAPEUTICS | TENAX THERAPEUTICS, INC | 2012-07-19 | — | — | US | disclosed |
| US-8101117-B2 | Controlled gas pore formers in extruded ware | CORNING, INCORPORATED (US) | 2012-01-24 | — | — | US | disclosed |
| EP-2252333-A2 | GAS BASED WOUND AND TISSUE THERAPEUTICS | Oxygen Biotherapeutics, Inc. (US) | 2010-11-24 | — | — | EP | disclosed |
| US-20090298667-A1 | Controlled Gas Pore Formers in Extruded Ware | CORNING INCORPORATED | 2009-12-03 | — | — | US | disclosed |
| WO-2009102487-A2 | GAS BASED WOUND AND TISSUE THERAPEUTICS | OXYGEN BIOTHERAPEUTICS, INC. (US) | 2009-08-20 | — | — | WO | disclosed |
| US-20090202617-A1 | Gas based wound and tissue therapeutics | TENAX THERAPEUTICS, INC | 2009-08-13 | — | — | US | disclosed |
| US-20090169630-A1 | Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications | VIRGINIA COMMONWEALTH UNIVERSITY | 2009-07-02 | — | — | US | disclosed |
| EP-2024287-A1 | METHODS AND COMPOSITIONS FOR CONTROLLED AND SUSTAINED PRODUCTION AND DELIVERY OF PEROXIDES | Virginia Commonwealth University (US) | 2009-02-18 | — | — | EP | disclosed |
| WO-2009006586-A2 | SELF-CONTAINED OXYGEN GENERATING AND BREATHING SYSTEMS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2009-01-08 | — | — | WO | disclosed |
| WO-2007134304-A1 | METHODS AND COMPOSITIONS FOR CONTROLLED AND SUSTAINED PRODUCTION AND DELIVERY OF PEROXIDES | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2007-11-22 | — | — | WO | disclosed |
| EP-0409612-A1 | Histidine-hydrogen peroxide adduct and process for preparing same | TOKAI DENKA KOGYO KABUSHIKI KAISHA (JP) | 1991-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090202617-A1 | Gas based wound and tissue therapeutics | PGF, FGF2, FGF1 | CYP3A4 3801/4885SLC7A5 4142/4885CPB2 2139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.